NYSE:RFL Rafael (RFL) Stock Price, News & Analysis $1.67 +0.07 (+4.38%) Closing price 04/17/2025 03:58 PM EasternExtended Trading$1.62 -0.05 (-2.99%) As of 04/17/2025 06:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Rafael Stock (NYSE:RFL) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Rafael alerts:Sign Up Key Stats Today's Range$1.57▼$1.7050-Day Range$1.61▼$2.0952-Week Range$1.29▼$2.50Volume42,587 shsAverage Volume31,868 shsMarket Capitalization$41.60 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewRafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1B clinical studies; Folate-targeted Promitil (Promi-Fol) which is aimed at local treatment (intravesical) of superficial bladder cancer; and Promi-Dox, a highly potent dual drug liposome with MLP and doxorubicin targeting a potential basket of tumors. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrumentation. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.Read More… Rafael Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks11th Percentile Overall ScoreRFL MarketRank™: Rafael scored higher than 11% of companies evaluated by MarketBeat, and ranked 884th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Rafael. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Rafael is -1.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Rafael is -1.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioRafael has a P/B Ratio of 0.48. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Rafael's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted0.86% of the float of Rafael has been sold short.Short Interest Ratio / Days to CoverRafael has a short interest ratio ("days to cover") of 5.5.Change versus previous monthShort interest in Rafael has recently increased by 55.70%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldRafael does not currently pay a dividend.Dividend GrowthRafael does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.86% of the float of Rafael has been sold short.Short Interest Ratio / Days to CoverRafael has a short interest ratio ("days to cover") of 5.5.Change versus previous monthShort interest in Rafael has recently increased by 55.70%, indicating that investor sentiment is decreasing significantly. News and Social Media2.6 / 5News Sentiment0.64 News SentimentRafael has a news sentiment score of 0.64. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Rafael this week, compared to 19 articles on an average week.Search Interest1 people have searched for RFL on MarketBeat in the last 30 days. MarketBeat Follows2 people have added Rafael to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Rafael insiders have not sold or bought any company stock.Percentage Held by Insiders10.20% of the stock of Rafael is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 11.30% of the stock of Rafael is held by institutions.Read more about Rafael's insider trading history. Receive RFL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Rafael and its competitors with MarketBeat's FREE daily newsletter. Email Address RFL Stock News HeadlinesFrench Open to honor Rafael Nadal with ceremony at opening of 2025 tournamentApril 18 at 2:15 PM | nytimes.comRafael Nadal: French Open to honour retired legend with special ceremonyApril 17 at 9:37 PM | msn.comNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. April 20, 2025 | Porter & Company (Ad)14-time French Open champion Rafael Nadal to be honoured with Roland Garros ceremonyApril 17 at 11:35 AM | msn.comRafael on Manchester United-Lyon: “With the ball, I think Lyon are the better team.”April 16, 2025 | sports.yahoo.com'Rafael Nadal beat me in a 'bullring' - there were blood stains on the floor!'April 16, 2025 | mirror.co.ukRed Sox won’t use Rafael Devers at 3B, so utility man called up for Alex Bregman’s spotApril 16, 2025 | msn.comHouston Astros complete trade with Braves for Rafael MonteroApril 12, 2025 | msn.comSee More Headlines RFL Stock Analysis - Frequently Asked Questions How have RFL shares performed this year? Rafael's stock was trading at $1.65 at the start of the year. Since then, RFL shares have increased by 1.2% and is now trading at $1.67. View the best growth stocks for 2025 here. How were Rafael's earnings last quarter? Rafael Holdings, Inc. (NYSE:RFL) announced its quarterly earnings results on Thursday, March, 13th. The company reported ($0.06) EPS for the quarter. The firm had revenue of $0.08 million for the quarter. Rafael had a negative trailing twelve-month return on equity of 53.71% and a negative net margin of 5,707.03%. Who are Rafael's major shareholders? Rafael's top institutional investors include Wealth Enhancement Advisory Services LLC (0.05%). View institutional ownership trends. How do I buy shares of Rafael? Shares of RFL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Rafael own? Based on aggregate information from My MarketBeat watchlists, some other companies that Rafael investors own include NVIDIA (NVDA), Broadcom (AVGO), CrowdStrike (CRWD), ServiceNow (NOW), Adobe (ADBE), Arista Networks (ANET) and e.l.f. Beauty (ELF). Company Calendar Last Earnings3/13/2025Today4/20/2025Next Earnings (Estimated)6/12/2025Fiscal Year End7/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Pharmaceutical preparations Sub-IndustryReal Estate Current SymbolNYSE:RFL CIK1713863 Webwww.rafaelholdings.com Phone(212) 658-1450FaxN/AEmployees20Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.11) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-34,410,000.00 Net Margins-5,707.03% Pretax Margin-10,462.27% Return on Equity-53.71% Return on Assets-48.78% Debt Debt-to-Equity RatioN/A Current Ratio9.74 Quick Ratio9.74 Sales & Book Value Annual Sales$706,000.00 Price / Sales58.93 Cash FlowN/A Price / Cash FlowN/A Book Value$3.51 per share Price / Book0.48Miscellaneous Outstanding Shares24,913,000Free Float22,157,000Market Cap$41.60 million OptionableOptionable Beta0.99 Free Today: Your Guide to Smarter Options TradesLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NYSE:RFL) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rafael Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rafael With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.